GeneMatrix Inc.

A109820

KR7109820001

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-06-11 EDT			5-day change	1st Jan Change
2,490 ^KRW	-0.40%		+1.63%	-19.81%

2023	GeneMatrix Inc.(KOSDAQ:A109820) dropped from S&P Global BMI Index	CI
2021	GeneMatrix Inc.(KOSDAQ:A109820) added to S&P Global BMI Index	CI

GeneMatrix Inc.'s Equity Buyback Plan Extended till January 2013.

July 26, 2012 at 12:00 am

On July 26, 2012, the company extended its share repurchase program until January 26, 2013.

Latest news about GeneMatrix Inc.

GeneMatrix Inc.(KOSDAQ:A109820) dropped from S&P Global BMI Index	23-09-18	CI
GeneMatrix Inc.(KOSDAQ:A109820) added to S&P Global BMI Index	21-09-20	CI
Vaccitech Limited announced that it has received £6 million in funding from GeneMatrix Inc., Korea Investment Partners Co. Ltd.	18-12-19	CI
GeneMatrix Inc. announced that it has received KRW 6.99999647 billion in funding from Korea Investment Partners Co. Ltd.	18-12-12	CI
GeneMatrix Inc. announced that it expects to receive KRW 6.99999647 billion in funding from Korea Investment Partners Co. Ltd.	18-12-04	CI
GeneMatrix Inc. announced that it has received KRW 3.5 billion in funding	18-02-08	CI
GeneMatrix Inc. announced that it has received KRW 6.5 billion in funding	18-01-29	CI
GeneMatrix Inc. announced that it expects to receive KRW 3.5 billion in funding	18-01-28	CI
GeneMatrix Inc. announced that it expects to receive KRW 6.5 billion in funding	18-01-28	CI
GeneMatrix Inc. announced that it has received KRW 5 billion in funding from KB Investment Co., Ltd., ID Ventures, POSCO Venture Capital Co., Ltd..	15-07-26	CI
GeneMatrix Inc. announced that it expects to receive KRW 5 billion in funding from KB Investment Co., Ltd., ID Ventures, POSCO Venture Capital Co., Ltd..	15-07-23	CI
GeneMatrix Inc.'s Equity Buyback announced on January 27, 2011 has expired.	14-07-26	CI
Tranche Update on GeneMatrix Inc.'s Equity Buyback Plan announced on January 27, 2011.	14-07-24	CI
GeneMatrix Inc.'s Equity Buyback Plan Extended till July 26, 2014.	14-01-23	CI
GeneMatrix Inc.'s Equity Buyback Plan Extended till January 26, 2014	13-07-19	CI
GeneMatrix Inc.'s Equity Buyback Plan Extended till July 27, 2013	13-01-24	CI
GeneMatrix Inc.'s Equity Buyback Plan Extended till January 2013.	12-07-26	CI
GeneMatrix Inc.'s Equity Buyback Plan Extended till July 26, 2012.	12-01-25	CI

GENEMATRIX Inc. is a Korea-based company mainly engaged in biotechnology business. The Company operates in two segments: pharmaceutical development and diagnostic medicine. Its pharmaceutical development segment specializes in the development of restriction fragment mass polymorphism (RFMP) genotyping technology for diagnosis of hepatitis B virus (HBV), hepatitis C virus (HCV), human papillomavirus (HPV) and others. Its diagnostic medicine segment specializes in the manufacture and sale of liver-function examination reagents, and import and sale of medical equipment and reagents.

Sector

Biotechnology & Medical Research

Calendar

2024-08-13 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
GENEMATRIX INC.	-19.81%	37.19M
MODERNA, INC.	+48.54%	56.61B
LONZA GROUP AG	+36.53%	39.25B
IQVIA HOLDINGS INC.	-6.02%	39.62B
CELLTRION, INC.	-6.90%	28.28B
ICON PUBLIC LIMITED COMPANY	+12.97%	26.44B
ALNYLAM PHARMACEUTICALS, INC.	-16.91%	20.12B
MEDPACE HOLDINGS, INC.	+31.71%	12.48B
UNITED THERAPEUTICS CORPORATION	+28.18%	12.51B
BIO-TECHNE CORPORATION	+0.38%	12.2B

Other Biotechnology & Medical Research

GeneMatrix Inc.

Equities

A109820

KR7109820001

Biotechnology & Medical Research

GeneMatrix Inc.'s Equity Buyback Plan Extended till January 2013.

Latest news about GeneMatrix Inc.

Chart GeneMatrix Inc.

Company Profile

Sector Other Biotechnology & Medical Research